{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:59:57Z","timestamp":1785214797627,"version":"3.55.0"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Camurati\u2013Engelmann Disease (CED) is a rare sclerosing bone dysplasia in which skull-base hyperostosis may result in neuro-ophthalmic complications. We report a 21-year-old woman with presumed CED and known bilateral choroidal osteomas who presented with bilateral optic nerve swelling. Neuroimaging demonstrated diffuse cranial hyperostosis with optic canal narrowing but no definitive optic nerve compression or venous sinus thrombosis. Lumbar puncture confirmed raised intracranial pressure with an opening pressure of 33\u202fcm H\u2082O. Optical coherence tomography revealed right eye subretinal fluid without choroidal neovascular membrane. Papilloedema improved initially with acetazolamide, but treatment was changed to oral furosemide due to intolerance to acetazolamide. There was continued visual decline in association with progressive subretinal fluid. Right eye intravitreal bevacizumab was ineffective, while fovea-sparing photodynamic therapy achieved resolution of subretinal fluid but was complicated by retinal pigment epithelial and photoreceptor loss. At 2.5-year follow-up, visual acuity was reduced in both eyes, with mild bilateral chronic papilloedema and enlargement of choroidal osteomas. This case illustrates multifactorial visual loss in CED with skull base hyperostosis arising from raised intracranial pressure and co-existing retinochoroidal pathology. This is the first documented case of CED with bilateral choroidal osteomas and highlights the role of multimodal imaging and multidisciplinary collaboration.<\/jats:p>","DOI":"10.3389\/fneur.2026.1831878","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:25:48Z","timestamp":1785212748000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Vision-threatening manifestations of choroidal osteomas and papilloedema in presumed Camurati-Engelmann disease"],"prefix":"10.3389","volume":"17","author":[{"given":"Anika","family":"Rao","sequence":"first","affiliation":[{"name":"Department of Clinical Education, Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust","place":["Leicester, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Cristescu","sequence":"additional","affiliation":[{"name":"Ocular Oncology Service, Department of Ophthalmology, Royal Hallamshire Hospital","place":["Sheffield, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hibba","family":"Quhill","sequence":"additional","affiliation":[{"name":"Ocular Oncology Service, Department of Ophthalmology, Royal Hallamshire Hospital","place":["Sheffield, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umiya","family":"Harley","sequence":"additional","affiliation":[{"name":"Ocular Oncology Service, Department of Ophthalmology, Royal Hallamshire Hospital","place":["Sheffield, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satheesh","family":"Ramalingam","sequence":"additional","affiliation":[{"name":"Department of Neuroradiology, University Hospitals Birmingham NHS Foundation Trust","place":["Birmingham, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Tsermoulas","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Hospitals Birmingham NHS Foundation Trust","place":["Birmingham, United Kingdom"]},{"name":"Metabolism and Systems Science, School of Medical Sciences, University of Birmingham","place":["Birmingham, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan P.","family":"Mollan","sequence":"additional","affiliation":[{"name":"Metabolism and Systems Science, School of Medical Sciences, University of Birmingham","place":["Birmingham, United Kingdom"]},{"name":"Department of Ophthalmology, Queen\u2019s University","place":["Kingston, ON, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Berman","sequence":"additional","affiliation":[{"name":"Metabolism and Systems Science, School of Medical Sciences, University of Birmingham","place":["Birmingham, United Kingdom"]},{"name":"Birmingham Neuro-Ophthalmology, University Hospitals Birmingham NHS Foundation Trust","place":["Birmingham, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jmg.2005.033522","article-title":"Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment","volume":"43","author":"Janssens","year":"2006","journal-title":"J Med Genet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1001\/archoto.2010.68","article-title":"Skull base manifestations of Camurati-Engelmann disease","volume":"136","author":"Carlson","year":"2010","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"ref3","article-title":"Camurati-Englemann Disease","volume-title":"GeneReviews","author":"Wallace","year":"2023"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1001\/archopht.1978.03910050204002","article-title":"Choroidal Osteoma","volume":"96","author":"Gass","year":"1978","journal-title":"Arch Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1001\/archopht.123.12.1658","article-title":"Factors predictive of tumor growth, tumor decalcification, choroidal neovascularization, and visual outcome in 74 eyes with choroidal osteoma","volume":"123","author":"Shields","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.4103\/tjo.TJO-D-24-00124","article-title":"Growing choroidal osteoma: treated by proton beam radiation","volume":"15","author":"Sedaghat","year":"2025","journal-title":"Taiwan J Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s00417-021-05487-4","article-title":"Complications, treatments, and visual prognosis of choroidal osteomas","volume":"260","author":"Seong","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.oret.2025.05.010","article-title":"Predictive factors and tumor dynamics in choroidal osteoma: a multimodal imaging-based longitudinal analysis","volume":"9","author":"Jacob","year":"2025","journal-title":"Ophthalmol Retina"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1136\/bjo.82.9.1042","article-title":"Papilloedema, a complication of progressive diaphyseal dysplasia: a series of three case reports","volume":"82","author":"Wright","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"7348","DOI":"10.1136\/bcr-2014-207348","article-title":"Bilateral papilloedema in Camurati-Engelmann disease","volume":"2015","author":"Popiela","year":"2015","journal-title":"BMJ Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1297\/cpe.2023-0009","article-title":"A case of papilledema in Camurati-Engelmann disease treated effectively with prednisolone","volume":"32","author":"Asai","year":"2023","journal-title":"Clin Pediatr Endocrinol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1001\/archopht.116.10.1337","article-title":"A long-term follow-up of choroidal osteoma","volume":"116","author":"Aylward","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1097\/IAE.0b013e3181c720ca","article-title":"Intravitreal bevacizumab in the management of subretinal fluid associated with choroidal osteoma","volume":"30","author":"Song","year":"2010","journal-title":"Retina"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"484","DOI":"10.4103\/2008-322X.176905","article-title":"Intravitreal bevacizumab for Management of Choroidal Osteoma without choroidal neovascularization","volume":"10","author":"Najafabadi","year":"2015","journal-title":"J Ophthalmic Vis Res"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/eye.2016.50","article-title":"Intravitreal bevacizumab monotherapy for choroidal neovascularisation secondary to choroidal osteoma","volume":"30","author":"Papastefanou","year":"2016","journal-title":"Eye"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"NP82","DOI":"10.1177\/11206721211000639","article-title":"Photodynamic therapy for macular choroidal osteoma","volume":"32","author":"Scupola","year":"2022","journal-title":"Eur J Ophthalmol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/sj.eye.6701475","article-title":"Choroidal neovascularization secondary to choroidal osteoma: successful treatment with photodynamic therapy","volume":"19","author":"Singh","year":"2005","journal-title":"Eye"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.survophthal.2023.06.002","article-title":"Clinical features and therapeutic management of choroidal osteoma: a systematic review","volume":"68","author":"Zhang","year":"2023","journal-title":"Surv Ophthalmol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1831878\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:25:49Z","timestamp":1785212749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1831878\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":18,"alternative-id":["10.3389\/fneur.2026.1831878"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1831878","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"article-number":"1831878"}}